Relief Therapeutics (RLFTF) News Today $5.55 -0.05 (-0.89%) (As of 11/21/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Relief Therapeutics Holding SA (RLF.SW)November 13, 2024 | finance.yahoo.comRELIEF THERAPEUTICS Holding AGOctober 30, 2024 | wsj.comRelief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional PatentsOctober 25, 2024 | markets.businessinsider.comRelief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis BullosaOctober 8, 2024 | markets.businessinsider.comRelief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for PhenylketonuriaOctober 4, 2024 | markets.businessinsider.comV6M.SG,0P0000PR2Y,0 (V6M.SG)August 8, 2024 | finance.yahoo.comRelief Therapeutics forms new executive leadership team, names new CFOMay 8, 2024 | msn.comRelief Therapeutics Holding SA (RLFTF)March 5, 2024 | ca.finance.yahoo.comRelief Therapeutics Announces CEO TransitionNovember 22, 2023 | finance.yahoo.comRelief Therapeutics Holding SA RLFTFNovember 15, 2023 | morningstar.comRelief Therapeutics Announces that more than 400,000 of its ADRs are Currently Outstanding and that, as a Result, the Company has Achieved an Important NASDAQ Initial Listing MilestoneOctober 10, 2023 | finance.yahoo.comRelief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 1, 2023 | finance.yahoo.comRelief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer TherapeuticsAugust 30, 2023 | finance.yahoo.comRelief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE® in the U.S. with Pentec HealthJuly 19, 2023 | finanznachrichten.deRelief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec HealthJuly 19, 2023 | finance.yahoo.comRelief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE(R) in the Middle EastJune 23, 2023 | finance.yahoo.comRELIEF THERAPEUTICS Holding SA Announces Closing of CHF 5 Million Private PlacementJune 23, 2023 | uk.sports.yahoo.comRELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of ShareholdersJune 20, 2023 | finance.yahoo.comRELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting of ShareholdersJune 20, 2023 | finance.yahoo.comRelief Therapeutics announces CHF 5M private placementJune 16, 2023 | msn.comRELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private PlacementJune 16, 2023 | finance.yahoo.comRelief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant LaboratoryMay 15, 2023 | finance.yahoo.comRelief Therapeutics Has Filed its 2022 Annual Report on Form 20-F with the U.S. Securities and Exchange CommissionMay 12, 2023 | finance.yahoo.comRelief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary SharesMay 3, 2023 | finance.yahoo.comRelief Therapeutics Announces Executive Leadership Team ChangeApril 5, 2023 | finance.yahoo.comRelief Therapeutics Holding SA to Hold Extraordinary General Meeting of ShareholdersApril 4, 2023 | finance.yahoo.comRelief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory BoardApril 3, 2023 | markets.businessinsider.comRelief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023March 22, 2023 | finance.yahoo.comRelief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual MeetingMarch 17, 2023 | finance.yahoo.comRelief Therapeutics Announces Availability of New PKU GOLIKE BARs in EuropeMarch 16, 2023 | finance.yahoo.comRelief Therapeutics Provides Update From Collaboration Partner on OLPRUVAMarch 15, 2023 | finance.yahoo.comRelief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis BullosaFebruary 14, 2023 | finance.yahoo.comRelief pulls Nasdaq IPO filing of ADSs with aim to list ordinary shares on exchangeFebruary 8, 2023 | msn.comRelief Therapeutics Provides an Update on its Financing StrategyFebruary 8, 2023 | finance.yahoo.comRelief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell LymphomJanuary 17, 2023 | finance.yahoo.comAcer wins FDA OK for Olpruva to treat urea cycle disordersDecember 23, 2022 | seekingalpha.comSwiss drug developer Relief Therapeutics upsizes proposed offering to $25MDecember 23, 2022 | msn.comRelief Therapeutics Announces Issuance of Shares from Authorized CapitalDecember 13, 2022 | finance.yahoo.comRelief Therapeutics Announces Executive Leadership Team ChangesDecember 8, 2022 | finance.yahoo.comAPR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film FestivalNovember 21, 2022 | finance.yahoo.comAPR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film FestivalNovember 21, 2022 | finance.yahoo.comRelief, NRx reach settlement over COVID-19 therapy aviptadilNovember 14, 2022 | seekingalpha.comRelief Therapeutics Holding SA and NRx Pharmaceuticals, inc. Further Extend their Stay of Pending Litigation to Provide Additional Time for the Parties to Finalize their Litigation SettlementNovember 8, 2022 | finance.yahoo.comRelief reports stability data on new formulation of lung disease drug RLF-100November 7, 2022 | seekingalpha.comRELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. Extend Their Stay of Pending Litigation to Provide Additional Time for The Parties to Finalize Their SettlementOctober 26, 2022 | finance.yahoo.comRelief Announces U.S. Launch of PKU GOLIKEOctober 10, 2022 | finance.yahoo.comRelief Announces Exclusive Distributor for PKU GOLIKE in the U.S.October 6, 2022 | finance.yahoo.comAcer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium BenzoateOctober 3, 2022 | finance.yahoo.comRelief says Nexodyn's trial for rare skin disorder gets IRB approvalSeptember 22, 2022 | seekingalpha.comRelief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of ChicagoSeptember 22, 2022 | finance.yahoo.com Get Relief Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLFTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. RLFTF Media Mentions By Week RLFTF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RLFTF News Sentiment▼0.000.47▲Average Medical News Sentiment RLFTF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RLFTF Articles This Week▼00▲RLFTF Articles Average Week Get Relief Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLFTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News AKBLF News DRTSW News ARNI News ASPHF News ASCLF News AVCTF News AWKNF News AXIM News BRRGF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RLFTF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relief Therapeutics Holding SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Relief Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RLFTF Stock Alerts